FLEMINGTON, N.J., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced that Chief Executive Officer Alex Zukiwski, M.D., is scheduled to present at the Annual LD Micro Conference, being held December 2-4, 2014 at the Luxe Hotel in Los Angeles, CA.
Dr. Zukiwski will present on Thursday, December 4, 2014 at 12:30 p.m. PT to attending investors. During his presentation, Dr. Zukiwski will discuss Arno's business and growth strategy, latest clinical developments and anticipated milestones for its lead oncology candidate, onapristone.
Details of the presentation are as follows:
|Date:||Thursday, December 4, 2014|
|Time:||12:30 p.m. PT|
|Location:||Luxe Hotel, Los Angeles, CA|
Attending investors who would like to schedule a 1-on-1 meeting with Arno management during the conference may do so by contacting Lee Roth (firstname.lastname@example.org) or Joseph Green (email@example.com) of The Ruth Group.
About Arno Therapeutics
Arno Therapeutics is a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer. Arno has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates. These compounds are in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors. For more information about the company, please visit www.arnothera.com.
CONTACT: The Ruth Group Lee Roth (investors) firstname.lastname@example.org (646) 536-7012 Kirsten Thomas (media) email@example.com (646) 536-7014 Arno Therapeutics Lawrence Kenyon firstname.lastname@example.org (862) 703-7171
Source:Arno Therapeutics Inc.